Drug Discovery Automation - HCS & Cell Based Assays

Agenda Topics

• Advances in HCA Miniaturization: From Hardware to Software
• Applications of HCS in Drug Toxicity, Safety and Pollution Assessment
• HCS Based RNAi Target Validation and Biomarker Discovery
• Image Acquisition and Analysis of 3D Cell Culture Based Models
• Image Acquisition and Analysis of Tissues and Whole Model Organisms
• Live Cells Imaging for Chemical and RNAi Screening
• Novel Reagents and Probes for use in High Content Assay Development
• Use of Primary Cells in High Content Screening

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

Veit Bergendahl, Head, Miltenyi Biotec GmbH
Thierry Dorval, Team Leader, Institut Pasteur Korea
Rosemary Drake, Chief Scientific Officer, TAP Biosystems
Cedric Gaggioli, Senior Postdoctoral Fellow/Research Fellow, Universite Nice Sophia Antipolis
Carsten Grotzinger, Group Leader/Head, Charite University Medicine Berlin
Johnny Kim, Group Leader, Max Planck Institute for Heart and Lung Research
Karol Kozak, Head, ETH Zurich
Kim Luu, Director, IntelliCyt Corporation
Maria Montoya, Head, National Center for Cardiovascular Research
Katya Tsaioun, CSO, Cyprotex
Gerardo Turcatti, Director, Ecole Polytechnique Federale De Lausanne
Andras Visegrady, Head, Lead Discovery Laboratory, Gedeon Richter
Karen Vrijens, Postdoctoral Researcher, St Jude Children's Research Hospital
Carsten Wenzel, Scientist, Bayer Healthcare
Ann Wheeler, Advanced Imaging Facility Manager, Queen Mary University of London
Peter Zehetmayer, Sales Specialist Cell Technologies, GE Healthcare
Daniel Zicha, Head of Light Microscopy, Cancer Research UK